Hutch News

Hutch News

Stories tagged 'Stanley R Riddell'

Fred Hutch collaborates with new Allen Institute for Immunology

Multipartner initiative aims to map the immune system in health and disease

Dec. 12, 2018 | By Sabrina Richards / Fred Hutch News Service

Researchers from Fred Hutchinson Cancer Research Center will partner with the new Allen Institute for Immunology to chart the human immune system by harnessing big data and emerging technologies.

View story >


'Exciting' but early results in trial of immunotherapy for myeloma

Cancer cells disappeared rapidly in patients with high-risk, treatment-resistant disease

Dec. 3, 2018 | by Susan Keown / Fred Hutch News Service

The patients were out of options to treat their advanced myelomas. Then, they enrolled on a new clinical trial of genetically reprogrammed immune cells called CAR T cells.

View story >


Colette Chaney named ‘2018 Nurse of the Year for Research Advancement’

March of Dimes Washington honors the longtime immunotherapy clinical research nurse

Nov. 19, 2018 | By Jake Siegel / Fred Hutch News Service

The longtime immunotherapy clinical research nurse has received the March of Dimes Washington's 2018 Nurse of the Year for Research Advancement.

View story >


Forbes ’30 Under 30’ lists Hutch immunotherapy researcher Alex Salter

Grad student on short list of young health care influencers

Nov. 14, 2018 | by Susan Keown / Fred Hutch News Service

For his research on cancer immunotherapy, Hutch grad student Alex Salter was named one of the top young health care innovators in the U.S. and Canada.

View story >


Dr. Marie Bleakley named Gerdin Family Endowed Chair for Leukemia Research

Pediatric cancer physician-scientist feted at rooftop reception

Aug. 30, 2018 | By Susan Keown / Fred Hutch News Service

Fred Hutch pediatric leukemia specialist Dr. Marie Bleakley has been named the Gerdin Family Endowed Chair for Leukemia Research, which was funded by the generosity of a patient family from Iowa.

View story >


Want to make better T-cell therapies? First, figure out how they work.

New study maps out activities, effects of widely used components in cellular immunotherapies

Aug. 21, 2018 | By Susan Keown / Fred Hutch News Service

This work "gives us a direction" to create better, next-gen versions of this type of cancer immunotherapy, called CAR T-cell therapy, the researchers said.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.